2000
Site Expansion to Feature Patient Information on Cardiac Arrhythmias Indianapolis, IN - To increase patient awareness of lifesaving and life-enhancing therapy options for cardiac arrhythmias and...
Indianapolis, Ind. and Cupertino, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the development of minimally invasive technology to treat coronary artery disease, announced...
Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, announced today CE Mark approval of its MULTI-LINK...
Indianapolis, Ind. and Tokyo, Japan - In an effort to broaden and accelerate the access of Guidant's lifesaving and life-enhancing medical technologies to the Japanese population, Guidant...
Nearly 75% of Patients Treated with ANCURE Bifurcated System Implant Experience Decreasing Aneurysm Size Over Time Indianapolis, IN - Three-year follow-up data on Guidant's (NYSE and PCX: GDT)...
Indianapolis, Ind. and Santa Clara, Calif. - Clinical data from a recent clinical trial sponsored by Guidant Corporation (NYSE and PCX: GDT) demonstrate that coronary stenting is a safe and...
Biliary Stent Further Extends Company''s Line of Non-Coronary Stent Systems Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...
PRIZM 2 and MULTI-LINK TETRA Provide Foundation for Fourth Quarter Growth Indianapolis, IN - Reporting strong implantable defibrillator, pacemaker, and angioplasty revenues as well as growth from...
Diagnosing Abdominal Aortic Aneurysms A Growing Concern for Family and Primary Care Physicians Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in the medical technology...
INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its third quarter 2000 earnings conference call on...